Victoria B. Knick

2.0k total citations
10 papers, 833 citations indexed

About

Victoria B. Knick is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Victoria B. Knick has authored 10 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Victoria B. Knick's work include Cancer Treatment and Pharmacology (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Ubiquitin and proteasome pathways (2 papers). Victoria B. Knick is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Ubiquitin and proteasome pathways (2 papers). Victoria B. Knick collaborates with scholars based in United States, Netherlands and United Kingdom. Victoria B. Knick's co-authors include Mui Cheung, Tona M. Gilmer, Jeffrey A. Stafford, Robert J. Mullin, Sharon K. Rudolph, Anne T. Truesdale, Rakesh Kumar, Andrea H. Epperly, James A. Onori and Ming‐Chih Crouthamel and has published in prestigious journals such as Cancer, Antimicrobial Agents and Chemotherapy and Molecular Cancer Therapeutics.

In The Last Decade

Victoria B. Knick

10 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victoria B. Knick United States 9 434 290 232 123 108 10 833
Erik Corcoran United States 9 215 0.5× 189 0.7× 86 0.4× 46 0.4× 89 0.8× 12 481
Yingjun Yan China 14 304 0.7× 283 1.0× 295 1.3× 48 0.4× 33 0.3× 29 726
Faribourz Payvandi United States 15 815 1.9× 479 1.7× 149 0.6× 38 0.3× 42 0.4× 19 1.6k
Yingchun Xu China 18 421 1.0× 493 1.7× 222 1.0× 37 0.3× 103 1.0× 75 1.2k
Leanne Cartee United States 14 357 0.8× 226 0.8× 99 0.4× 24 0.2× 94 0.9× 27 646
Alain Piché Canada 27 994 2.3× 680 2.3× 108 0.5× 121 1.0× 112 1.0× 57 1.9k
Cassie M. Lane United States 14 231 0.5× 334 1.2× 148 0.6× 27 0.2× 77 0.7× 32 666
Marcel J. Flens Netherlands 13 565 1.3× 836 2.9× 90 0.4× 39 0.3× 83 0.8× 21 1.2k
Utz Krug Germany 25 1.1k 2.5× 432 1.5× 110 0.5× 92 0.7× 120 1.1× 82 2.0k
Sharmila Makhija United States 19 569 1.3× 416 1.4× 83 0.4× 37 0.3× 34 0.3× 42 1.2k

Countries citing papers authored by Victoria B. Knick

Since Specialization
Citations

This map shows the geographic impact of Victoria B. Knick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria B. Knick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria B. Knick more than expected).

Fields of papers citing papers by Victoria B. Knick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria B. Knick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria B. Knick. The network helps show where Victoria B. Knick may publish in the future.

Co-authorship network of co-authors of Victoria B. Knick

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria B. Knick. A scholar is included among the top collaborators of Victoria B. Knick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria B. Knick. Victoria B. Knick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lin, Hong, Dennis S. Yamashita, Jin Zeng, et al.. (2009). 2,3,5-Trisubstituted pyridines as selective AKT inhibitors—Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivity. Bioorganic & Medicinal Chemistry Letters. 20(2). 673–678. 11 indexed citations
2.
Emmitte, Kyle A., C. Webb Andrews, Ronda G. Davis‐Ward, et al.. (2008). Discovery of thiophene inhibitors of polo-like kinase. Bioorganic & Medicinal Chemistry Letters. 19(3). 1018–1021. 33 indexed citations
3.
Stevens, Kirk L., Michael J. Reno, Daniel J. Price, et al.. (2008). Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(21). 5758–5762. 26 indexed citations
4.
Kumar, Rakesh, Victoria B. Knick, Sharon K. Rudolph, et al.. (2007). Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity. Molecular Cancer Therapeutics. 6(7). 2012–2021. 423 indexed citations
5.
Lansing, Timothy J., Randy T. McConnell, Derek R. Duckett, et al.. (2007). In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1. Molecular Cancer Therapeutics. 6(2). 450–459. 122 indexed citations
6.
Veal, James M., Robert T. Nolte, Liping Wang, et al.. (2005). Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 15(15). 3519–3523. 27 indexed citations
7.
Laufman, Leslie R., Wayne D. Brenckman, Mary Collier, et al.. (1989). Clinical experience with leucovorin and 5-fluorouracil. Cancer. 63(S6). 1031–1035. 23 indexed citations
8.
Laufman, Leslie R., Wayne D. Brenckman, Mary Collier, et al.. (1988). Clinical Experience with CF-FUra. Advances in experimental medicine and biology. 244. 201–211. 1 indexed citations
9.
Elwell, Lynn P., Robert Ferone, George A. Freeman, et al.. (1987). Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U). Antimicrobial Agents and Chemotherapy. 31(2). 274–280. 128 indexed citations
10.
Elwell, Lynn P., H.R. WILSON, Victoria B. Knick, & Barry R. Keith. (1986). In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 29(6). 1092–1094. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik Corcoran Breakdown of academic impact, for papers by Yingjun Yan Breakdown of academic impact, for papers by Faribourz Payvandi Breakdown of academic impact, for papers by Yingchun Xu Breakdown of academic impact, for papers by Leanne Cartee Breakdown of academic impact, for papers by Alain Piché Breakdown of academic impact, for papers by Cassie M. Lane Breakdown of academic impact, for papers by Marcel J. Flens Breakdown of academic impact, for papers by Utz Krug Breakdown of academic impact, for papers by Sharmila Makhija
Rankless by CCL
2026